Craig C. Hopkinson - Feb 12, 2025 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
EVP R&D, Chief Medical Officer
Signature
/s/ Shantale Greenson, attorney-in-fact for Craig C. Hopkinson
Stock symbol
ALKS
Transactions as of
Feb 12, 2025
Transactions value $
-$3,586,007
Form type
4
Date filed
2/14/2025, 05:12 PM
Previous filing
Feb 7, 2025
Next filing
Feb 20, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Options Exercise $1.75M +87.6K +137.68% $20.03 151K Feb 12, 2025 Direct F1
transaction ALKS Ordinary Shares Options Exercise $2.16M +112K +73.85% $19.34 263K Feb 12, 2025 Direct F1
transaction ALKS Ordinary Shares Sale -$5.62M -172K -65.38% $32.69 91K Feb 12, 2025 Direct F2, F3
transaction ALKS Ordinary Shares Sale -$1.1M -33.1K -36.39% $33.27 57.9K Feb 12, 2025 Direct F2, F4
transaction ALKS Ordinary Shares Options Exercise $3.48M +109K +188.05% $31.93 167K Feb 13, 2025 Direct F1
transaction ALKS Ordinary Shares Options Exercise $875K +35.6K +21.35% $24.59 202K Feb 13, 2025 Direct F1
transaction ALKS Ordinary Shares Sale -$1.21M -35.6K -17.59% $34.02 167K Feb 13, 2025 Direct F2, F5
transaction ALKS Ordinary Shares Sale -$3.92M -109K -65.28% $36.02 57.9K Feb 13, 2025 Direct F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKS Employee Stock Option (Right to Buy) Options Exercise $0 -87.6K -100% $0.00 0 Feb 12, 2025 Ordinary Shares 87.6K $20.03 Direct F1, F7
transaction ALKS Employee Stock Option (Right to Buy) Options Exercise $0 -112K -69.02% $0.00 50.1K Feb 12, 2025 Ordinary Shares 112K $19.34 Direct F1, F8
transaction ALKS Employee Stock Option (Right to Buy) Options Exercise $0 -109K -100% $0.00 0 Feb 13, 2025 Ordinary Shares 109K $31.93 Direct F1, F7
transaction ALKS Employee Stock Option (Right to Buy) Options Exercise $0 -35.6K -33.33% $0.00 71.2K Feb 13, 2025 Ordinary Shares 35.6K $24.59 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023.
F2 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.9998. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.00 to $33.52. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.00 to $34.07. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
F6 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.00 to $36.05. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
F7 These options are fully vested in accordance with their terms.
F8 Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022.
F9 Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023.